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M2 macrophage is the predominant
phenotype in airways inflammatory lesions
in patients with granulomatosis with
polyangiitis
Alexandre Wagner Silva de Souza1,2* , Mirjan van Timmeren3, Jan-Stephan Sanders4, Coen Stegeman4,
Peter Heeringa3, Cees G. M. Kallenberg1 and Johanna Westra1
Abstract
Background: Macrophages may present two distinct phenotypes indicated as M1 and M2 under different stimuli.
M1 and M2 macrophages have divergent functions that range from enhancement of inflammation for M1 to tissue
repair and remodeling for M2 macrophages. The objective of this study was to evaluate the distribution of M1 and
M2 macrophage phenotypes in biopsies from the airways of patients with active granulomatosis with polyangiitis
(GPA) and to analyze their associations with T and B cells in those biopsies, and with nasal carriage of Staphylococcus
aureus, disease parameters and therapy.
Methods: Consecutive GPA patients (n = 35) with active airway disease, who underwent respiratory tract biopsy were
included. Immunohistochemical evaluation was performed to assess the distribution of macrophages and T and B cells
using the markers CD68, CD3 and CD20, respectively. CD86 was used as the M1 marker and CD163 as the M2
marker while Tbet and GATA-3 were used as Th1 and Th2 markers, respectively. At the time of the biopsy patients
were assessed for nasal carriage of Staphylococcus aureus and treatment.
Results: Percentages of macrophages and T cells were significantly higher than those of B cells in lesional tissue from
the respiratory tract in GPA. M2 macrophages and Th2 cells were more frequent than M1 macrophages (p = 0.0007)
and Th1 cells (p < 0.0001), respectively. Percentages of T cells were higher in nose biopsies than in biopsies from other
sites (p = 0.021); macrophages and CD163+ macrophages were more predominant in biopsy sites other than the
nose (p = 0.039 and p = 0.012, respectively). Carriage of Staphylococcus aureus was associated with higher T cell
scores (p = 0.014). The frequency of macrophages, especially M2 macrophages, was higher in GPA patients treated
with immunosuppressive agents (p = 0.010); daily prednisolone dose was positively correlated with all macrophage
markers. However, in multivariate analysis no independent associations were found between disease parameters
and therapy with macrophage markers or T cells.
Conclusion: In GPA, M2 is the predominant macrophage phenotype in the respiratory tract. Although some
associations were observed between macrophages and T cells with therapy and nasal carriage of Staphylococcus
aureus, they were not independently significant in multivariate analysis.
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Background
Granulomatosis with polyangiitis (GPA) is a type of
antineutrophil cytoplasmic antibody (ANCA)-associ-
ated vasculitis characterized by necrotizing granuloma-
tous inflammation and small to medium-sized vessel
vasculitis, which may involve multiple organs [1, 2]. In
GPA, granulomatous inflammation usually involves the
upper and lower respiratory tract and the orbits and
meninges, leading to mass formation (e.g. pulmonary
nodules or masses, orbital masses, subglottic and/or
bronchial stenosis, hypertrophic pachimeningitis) and
destructive lesions such as bony erosions of the si-
nuses, saddle nose, septal perforation or cavitation of
pulmonary nodules/masses [3, 4]. Once regarded as a
relatively harmless phenotype of GPA due to its expres-
sion mainly in patients with localized disease, recent
studies have shown that necrotizing granulomatous in-
flammation may lead to significant morbidity and even
death in GPA, and it is often refractory to conventional
treatment [5, 6].
Macrophages are cells of the innate immune system
that play an important role in inflammation, host
defense, tissue remodeling and regulation of metabolism
[7]. The plasticity of macrophages is highlighted by their
capacity to change their functional phenotypes in re-
sponse to distinct stimuli. Stimulation by toll-like recep-
tor (TLR) ligands or by interferon (IFN)-γ triggers M1
polarization, while the exposure to cytokines like inter-
leukin (IL)-4 and/or IL-13 leads to M2 polarization, mir-
roring T helper (Th) Th1/Th2 polarization of T cells [8].
M1 macrophages usually express IL-12 and IL-23, pro-
duce effector molecules (e.g. reactive oxygen and nitro-
gen species) and inflammatory cytokines such as IL-1β,
tumor necrosis factor α (TNFα) and IL-6. These M1
macrophages initiate an inflammatory response and
mediate tissue damage, and they are responsible for re-
sistance to intracellular pathogens and tumor cells. In
contrast, M2 macrophages express IL-10 and a high
level of scavenger-like, mannose-like and galactose-like
receptors. M2 macrophages are involved in inhibiting
inflammation, in tissue repair and remodeling and in
angiogenesis and tumor progression [7, 8]. Nonetheless,
M2 macrophages are further sub classified into four
different additional phenotypes as follows: M2a, M2b,
M2c and M2d, with distinct functions. M2a is a wound-
healing macrophage that promotes tissue repair and re-
modeling while M2c is a suppressor macrophage that is
responsible for downregulating immune response. M2b
macrophage is a pro-inflammatory M2 macrophage that
is induced by exposure to immune complexes, TLR li-
gands or IL-1 receptor antagonist. M2d macrophages
produce high levels of IL-10 and vascular endothelial
growth factor (VEGF), inhibiting immune response and
promoting angiogenesis [9].
Macrophages are key cells in granulomatous inflam-
mation and may be present as epithelioid cells, multinu-
cleated giant cells and in some instances as foam cells
[10]. Granulomatous inflammation in GPA is character-
ized by poorly formed granulomas usually associated
with geographic necrosis, micro abscesses and scattered
giant cells [11, 12].
In the early stages of ANCA-associated pauci-immune
necrotizing glomerulonephritis, CD163+ M2 macro-
phages predominate at sites of fibrinoid necrosis, where
they exceed the numbers of neutrophils and T cells.
CD68+ cells and CD163+ macrophages are more fre-
quently found in normal-appearing glomeruli in this
condition than in glomeruli of controls with thin base-
ment membrane nephropathy [13]. However, to the best
of our knowledge, it is not known whether macrophages
found in granulomatous lesions in the upper airways of
patients with GPA display an M1 or M2 phenotype.
Assessment of their distribution would help to uncover
whether granulomatous inflammation in the airways of
patients with GPA displays a pro-inflammatory pheno-
type of macrophages in line with a Th1 response or a
more reparative and regulatory phenotype mirroring a
predominant Th2 response. We hypothesize that macro-
phages found in granulomatous lesions in the airways of
patients with GPA are predominantly of the M1 pheno-
type, due to the highly inflammatory nature of these
lesions and the Th1-polarized T cell response involved in
airway inflammation in patients with GPA. This study
aimed to investigate the distribution of macrophage phe-
notypes found in active granulomatous lesions in the
upper airways of patients with GPA and to analyze asso-
ciations with infiltrating T and B cells from these inflam-
matory sites and with chronic carriage of Staphylococcus
aureus, disease parameters and therapy in GPA.
Methods
Patients
Thirty-five consecutive patients who were classified as
having GPA according to the 1990 American College of
Rheumatology (ACR) criteria for GPA (Wegener’s granu-
lomatosis) or according to the European Medicines
Agency (EMEA) classification algorithm [14, 15], and
underwent a biopsy from the respiratory tract were se-
lected for this study. Disease extension was ascertained
according to European Vasculitis Study (EUVAS) disease
categorization of ANCA-associated vasculitis [16]. Table 1
describes disease features, biopsy sites, and therapy in
those patients with GPA. All biopsies were performed for
diagnostic purposes by nasofibroscopy, bronchoscopic
procedures or thoracotomy. The majority of patients with
GPA underwent nose biopsies; other biopsy sites (one pa-
tient per site) included ethmoidal sinus, Eustachian tube,
nasopharynx, subglottic area, trachea, bronchus and lung.
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The ANCA test was performed by in-house indirect
immunofluorescence (IIF) on ethanol-fixed neutrophil
slides and results were displayed as the pattern (i.e. cyto-
plasmic, perinuclear or atypical ANCA) and ANCA ti-
ters. ANCA specificity for anti-proteinase 3 (anti-PR3)
and anti-myeloperoxidase (anti-MPO) antibodies was
confirmed by an in-house capture enzyme-linked im-
munosorbent assay (ELISA) as described earlier [17].
Immunohistochemical evaluation
Biopsy specimens were processed for immunohisto-
chemical evaluation. Paraffin-embedded specimens and
formalin-fixed 4-μm sections were deparaffinized and
were incubated with 10 mM Tris/HCl and 1 mM EDTA
(Ethylenediaminetetraacetic acid) buffer (pH 9.0) at 90 °C
for 60 minutes for antigen retrieval. Endogenous peroxid-
ase was blocked with 0.3% H2O2 in phosphate-buffered
saline (PBS) for 30 minutes. Slides were pre-incubated
with 20% bovine serum albumin (BSA) and incubated with
the following primary antibodies diluted in PBS with 1%
BSA: anti-CD3 (Abcam, Bristol, UK), anti-CD20 (Abcam,
Bristol, UK), anti-CD68 (Abcam, Bristol, UK), anti-CD86
(Abcam, Bristol, UK) and anti-CD163 (Abcam, Bristol,
UK) for 1 hour at room temperature. Binding was de-
tected by appropriate horseradish-peroxidase-labeled sec-
ondary antibodies and peroxidase activity was developed
using 3, 3’-diaminobenzidine tetrachloride (10 minutes at
room temperature). To obtain nuclear staining for the
transcription factors Tbet and GATA-3 for Th1 and Th2
cells, respectively, 0.5% Triton was added to wash and in-
cubation buffer and anti-T-bet/Tbx21 clone 4B10 (Abcam,
Bristol, UK) and anti-GATA-3 (Abcam, Bristol, UK) anti-
bodies were used. For GATA-3 staining, antigen retrieval
was performed with citrate buffer (10 mM, pH 6.0).
All sections were stored digitally after examination using
a Nanozoomer Digital Pathology Scanner (NDP Scan
U10074-01; Hamamatsu Photonics K.K.) and quantified
using the positive pixel count algorithm with Image-
Scope Viewer software (V11.2.0.780 Aperio; e-Pathology
Solution). The percentage of strong positive brown and
positive pixels was determined in comparison to the
total number of pixels (positive and negative).
Statistical analysis
Data were analyzed using IBM SPSS Statistics for Win-
dows, version 20.0 (Armonk, USA) and graphs were built
using GraphPad Prism version 5.0 for Windows (La Jolla,
USA). Categorical variables were presented as total num-
ber and percentage while continuous data were presented
as mean ± standard deviation or as median and interquar-
tile range as appropriate. Student’s t test or the Mann-
Whitney U test was used for comparison of continuous
data between two groups, while comparisons between
three or more groups were performed using the Kruskal-
Wallis test. Correlation between variables was analyzed
using Spearman’s correlation coefficient. Univariate and
multivariate models of linear regression were built to
analyze associations between clinical and therapy variables
with frequencies of CD3, CD20, CD68, CD86 and CD163
in airway biopsies from patients with GPA. Results are
Table 1 Disease features and biopsy sites in patients with
granulomatosis with polyangiitis
Variables Results (n = 35)
Age, years 48.9 ± 12.6
Female, n (%) 22 (62.9)
Disease status
Onset, n (%) 9 (25.7)
Relapse, n (%) 25 (71.4)
Persistent disease, n (%) 1 (2.8)
Years since diagnosisa 8.7 ± 5.6
Disease extension
Localized disease, n (%) 29 (82.9)
Generalized disease, n (%) 6 (17.1)
Disease manifestations
ENT involvement, n (%) 34 (97.1)
Eye disease, n (%) 8 (22.8)
Lung involvement, n (%) 7 (20.0)
Glomerulonephritis, n (%) 4 (11.4)
Cutaneous vasculitis, n (%) 1 (2.8)
ANCA positivity
cANCA by IIF, n (%) 33 (94.3)
PR3-ANCA by ELISA, n (%) 32 (91.4)
Biopsy sites
Nose, n (%) 28 (80.0)
Other sites, n (%) 7 (20.0)
Staphylococcus aureus
Positive culture, n (%)b 19 (55.9)
Therapy
No therapy, n (%) 13 (37.1)
Prednisolone, n (%) 10 (28.6)
Prednisolone daily dose, mg 11.2 (9.3–20.0)
Daily co-trimoxazole, n (%) 14 (40.0)
Cyclophosphamide, n (%) 4 (11.4)
Azathioprine, n (%) 4 (11.4)
Methotrexate, n (%) 1 (2.8)
Mycophenolate mofetil, n (%) 4 (11.4)
Cyclosporin A, n (%) 1 (2.8)
Continuous variables are presented as mean and standard deviation or as
median and interquartile range as appropriate. ANCA antineutrophil cytoplasmic
antibodies, ELISA enzyme-linked immunosorbent assay, ENT ear, nose and throat,
IIF indirect immunofluorescence, n number of patients, PR3 proteinase 3. aYears
since diagnosis includes patients with relapsing and persistent disease. bResults
of nasal swab cultures were available for 34 patients
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expressed as β coefficient, p value and R2 as appropriate.
Statistical significance was set at 5% (p < 0.05).
Results
Macrophages and lymphocytes in airway lesions in GPA
Macrophage markers were more scattered throughout
inflammatory infiltrates while B and T cells were gathered
in nodules that resembled ectopic lymphoid-like struc-
tures (Fig. 1a-e). The percentage of macrophages and T
cells was significantly higher than that of B cells in inflam-
matory lesions of the airways from patients with GPA. No
difference was found between percentages of macrophages
and T cells (Fig. 2). Amongst macrophages, the frequency
of cells expressing the M2 marker CD163 was significantly
higher than that of cells expressing the M1 marker CD86
(p = 0.0007) (Fig. 3). Similar to what was found for M2
and M1 markers, the expression of the Th2 marker
GATA-3 amongst T cells was significantly higher than the
expression of the Th1 marker Tbet (1.229 ± 0.598 vs.
0.171 ± 0.382; p < 0.0001) (Fig. 4a-c). The frequency of T
cells was higher in nose biopsies in comparison with other
biopsy sites (p = 0.021) whereas the frequency of macro-
phages and CD163+ macrophages was significantly higher
in biopsy sites other than the nose (p = 0.039 and p =
0.012, respectively) (Table 2).
Lymphocytes, macrophages, disease parameters and
therapy in GPA
Airway biopsy scores for T cells, B cells and macrophages
were analyzed in relation to disease extension in GPA, dis-
ease onset or relapse, biopsy sites and positive nose culture
for Staphylococcus aureus. No significant differences were
found in lymphocytes or macrophages in relation to dis-
ease extension or disease onset/relapse (Additional file 1:
Table S1). However, a positive nose culture for Staphylo-
coccus aureus was associated with significantly higher T
Fig. 1 Representative figures of immunostainings of B cells (a), T cells (b), pan-macrophage marker CD68 (c), M1 macrophages (d) and M2
macrophages (e). B cells and T cells cluster in ectopic lymphoid-like structures with B cells centered and T cells in the periphery. Macrophages
are found scattered throughout the inflammatory infiltrate of nasal mucosa of a patient with granulomatosis with polyangiitis
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cell percentages compared with biopsies from patients
with a negative nose culture (10.5% (6.6–15.4) vs. 5.9%
(4.8–7.4); p = 0.014) (Additional file 1: Table S1 and Fig. 5).
There were no differences in T cell, B cell or macro-
phage scores between patients receiving and not receiving
any therapy (i.e. prednisolone and/or immunosuppressive
agents) (Additional file 2: Table S2), or between patients
receiving or not receiving co-trimoxazole, regardless of
whether they were chronic carriers of Staphylococcus
aureus (Additional file 2: Table S2). We observed a
trend towards lower percentages of T cells and higher
percentages of M2 macrophages in patients receiving
prednisolone compared with those not receiving pred-
nisolone (Additional file 2: Table S2). The percentage
of macrophages, especially M2 macrophages, was sig-
nificantly higher in patients with GPA treated with
immunosuppressive agents in comparison to those not
treated with these agents (Table 3 and Fig. 6a and b).
Distribution of T and B cells and macrophage subsets
in airway biopsies from patients with GPA was related to
the daily dose of prednisolone. There was significant
positive correlation between all macrophage markers and
the daily dose of prednisolone, including CD68 (rho =
0.858; p = 0.001), CD86 (rho = 0.753; p = 0.012) and
CD163 (rho = 0.759; p = 0.011). However, no correlation
was observed between CD3 or CD20 scores and the daily
dose of prednisolone (Additional file 3: Table S3).
In univariate analysis, positive nasal culture for
Staphylococcus aureus was significantly associated with
the frequency of T cells in airway biopsies from patients
with GPA (β = 4.99; p = 0.039; R2 = 0.127). However,
there was no association could be fond between the use
of co-trimoxazole and the frequency of T cells (β = 0.64;
p = 0.794). All macrophage markers (e.g. CD68, CD86
and CD163) were associated with daily prednisolone
dose and with the use of immunosuppressive agents
(Additional file 4: Table S4). Different models of multi-
variate linear regression were built using cell markers
(i.e. CD3, CD20, CD68, CD86 and CD163) as the
dependent variable and age, female gender, positive nasal
culture for Staphylococcus aureus, generalized disease,
use of co-trimoxazole, daily dose of prednisolone and
use of immunosuppressive agents as independent vari-
ables. Nonetheless, no significant independent associa-
tions were found with any cell marker in airway biopsies
from patients with GPA (Additional file 5: Table S5).
Discussion
In this study, we found that macrophages and T cells are
more frequent than B cells in airway lesions of patients
with GPA. M2 macrophages were the predominant
phenotype, mainly in airway sites other than the nose,
and this increase in M2 macrophages was further associ-
ated with the use of immunosuppressive agents. Frequen-
cies of macrophages and macrophage subsets were
significantly correlated with the daily dose of prednisolone
whereas B and T cells were not. Patients with GPA with a
positive nose culture for Staphylococcus aureus had higher
frequencies of T cells infiltrating the nose mucosa.
As macrophage phenotypes mirror Th1 and Th2 func-
tionality [8], and airway inflammation in GPA may be
predominantly from a Th1 response, we originally hypoth-
esized that the M1 phenotype would be more frequently
found in active lesions in the airways of patients with
GPA. However, this hypothesis was proven to be wrong
and the expression of the M2 marker CD163 and the Th2
marker GATA-3 was significantly higher in airway lesions
from patients with GPA. This unexpected finding may be
due to the ongoing Th2 response of patients with GPA
evaluated in this study, reflected by the frequent lymphoid
Fig. 3 Comparison of M1 and M2 macrophages scores in airway
biopsies from patients with granulomatosis with polyangiitis (GPA).
M2 macrophages are the predominant macrophage phenotype
found in airway biopsies from patients with GPA
Fig. 2 Lymphocytes and macrophages in airway biopsies from
patients with granulomatosis with polyangiitis (GPA). The frequency
of macrophages and T cells is significantly higher than that of B cells
in airway biopsies from patients with GPA. Percentages of T cells
and macrophages did not differ significantly
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follicles observed in parallel with granulomatous airway
inflammation and by the high frequency (94.3%) of a posi-
tive ANCA test, indicating a shift towards a Th2 response
[18]. Indeed, it is worth mentioning that sera from patients
with AAV had a tendency to shift towards an M2c pheno-
type in macrophages regardless of disease activity, whereas
sera from health controls led to an M0 phenotype [19]. Al-
ternatively, another mechanism to explain the predomin-
ant M2 phenotype in GPA is the influence of therapy on
our results; M2c macrophages may be induced by expos-
ure to glucocorticoids [20]. Although in this study only
one third of patients with GPA were under therapy with
prednisolone at a relatively low mean daily dose, there was
a trend toward higher scores of M2 macrophages and
lower scores of T cells in airway biopsies from patients
with GPA on prednisolone (Additional file 2: Table S2).
A recent study showed an increase in CD163+ M2
macrophages in early lesions of ANCA-associated
pauci-immune necrotizing glomerulonephritis, mostly
patients with either PR3- or MPO-ANCA. However, it
is not possible to associate this finding with therapy,
because no information was provided about the use of
glucocorticoids or immunosuppressive agents [13]. In
addition Park et al. found abundant expression of
CD163+ cells in granulomatous lesions in the lungs in
patients with GPA [21]. Together with our findings,
these results indicate that M2 polarization is observed
in different tissues affected by GPA, including the
upper airways, lungs and kidneys.
Macrophage polarization has been evaluated in tissues
from patients with different disorders. Every disease
Fig. 4 Representative figures of immunostaining of T cells (a), T helper (Th)1 (b) and Th2 (c) cells. The expression of the nuclear transcription
factor GATA-3 is (e.g. a Th2 marker) is significantly higher than that of Tbet (e.g. a Th1 marker) in airway biopsies from patients with granulomatosis
with polyangiitis
Table 2 Distribution of lymphocytes and macrophages in
biopsies from different sites of the airways of patients with
granulomatosis with polyangiitis
Variables Nose biopsy (n = 28) Biopsy from other sites (n = 7) p
CD3, % 8.3 (6.0–15.1) 5.2 (3.0–6.5) 0.021a
CD20, % 4.2 (2.4–7.5) 4.3 (1.9–10.7) 0.741
CD68, % 8.4 (6.3–13.6) 20.7 (7.2–29.6) 0.039a
CD86, % 16.9 (8.5–24.4) 29.5 (17.0–43.0) 0.114
CD163, % 31.7 ± 13.5 49.0 ± 21.7 0.012a
Data are presented as median and interquartile range or as mean and
standard deviation. aSignificant differences
Fig. 5 Positive nose culture for Staphylococcus aureus and CD3+
cells in airway biopsies from patients with granulomatosis with
polyangiitis (GPA). Patients with GPA with positive nose cultures
for Staphylococcus aureus presented with higher scores of T cells
in airway biopsies
de Souza et al. Arthritis Research & Therapy  (2017) 19:100 Page 6 of 10
shows a unique pattern of macrophage polarization that
may be influenced by the underlying pathophysiologic
process [8, 22]. The M1 phenotype is predominantly
found in adipose tissue in obese patients, in synovial
tissue in patients with rheumatoid arthritis, and in ath-
erosclerotic plaques [9, 22–28]. M2 macrophages are
predominantly found in muscle biopsies from patients
with neuromuscular sarcoidosis, in lung tissue from pa-
tients with idiopathic pulmonary fibrosis and from pa-
tients with asthma, and in synovial tissue from patients
with osteoarthritis and patients with spondyloarthritis
[23, 24, 29–32]. In cancer, M1-polarized macrophages
have anti-tumoral activity while infiltration of M2 mac-
rophages in tumoral lesions is associated with tumor
progression and with a worse prognosis [32]. Surface
markers have been used to identify M1 and M2 macro-
phages in different studies. The most common markers
used for M1 macrophages are CD80 and CD86, whereas
CD163 and mannose receptor (also known as CD206)
are used to characterize M2 macrophages [9].







CD3, % 8.0 (4.9–16.1) 7.3 (5.7–11.3) 0.891
CD20, % 4.0 (1.2–8.8) 5.0 (2.6–8.7) 0.322
CD68, % 13.3 (8.8–23.0) 7.7 (6.0–14.3) 0.034a
CD86, % 29.5 (11.9–41.8) 16.5 (8.2–23.4) 0.082
CD163, % 44.4 ± 18.3 29.8 ± 13.2 0.010a
Data are presented as median and interquartile range or as mean and standard deviation. aSignificant differences
Fig. 6 Relationship between immunosuppressive therapy and macrophages (CD68+ and CD163+ macrophages) in airway biopsies from patients
with granulomatosis with polyangiitis (GPA). Higher frequency of macrophages (a), especially M2 macrophages (b), is observed in airway biopsies
from patients with GPA on immunosuppressive therapy compared to patients not on immunosuppressive therapy
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In this study, we found higher percentages of CD86
and CD163, specific M1 and M2 markers, respectively,
compared with the pan-macrophage marker (CD68).
The possible reason for this may be the cytoplasmic dis-
tribution of CD68 in contrast with the membrane stain-
ing of CD86 and CD163 [33, 34]. Moreover, it is worth
mentioning that this was not a cellular count but a pixel
count of brown staining from immunohistochemistry
slides. In fact, some studies evaluating CD68 and CD163
by immunohistochemical evaluation also found higher
scores for CD163 compared with CD68 [12, 35–39].
Macrophages are polarized toward the M1 phenotype in
the early phases of bacterial infections, but when infection
becomes chronic or upon resolution and convalescence,
M2 macrophages prevail in order to prevent excessive
tissue damage [21]. Chronic carriage of Staphylococcus
aureus was included in this study due to its high preva-
lence in patients with GPA and its impact on the risk of
relapse [40]. Moreover, it would influence macrophage
polarization in inflammatory lesions of the airways in
GPA. Although in chronic rhinosinusitis with nasal polyps
an increased number of M2 macrophages and decreased
phagocytosis is associated with the persistence of
Staphylococcus aureus [41], we did not find any associ-
ation between an increased number of M2 macrophages
in nasal mucosa from patients with GPA and nasal car-
riage of Staphylococcus aureus. In the present study, the
association found between Staphylococcus aureus and T
cells in nasal mucosa could indicate that these bacteria
trigger local T cell expansion, as staphylococcal super-
antigens could be responsible for polyclonal T cell activa-
tion and an increased risk of relapse, especially strains of
Staphylococcus aureus that produce the tsst-1 (toxic shock
syndrome toxin-1) super-antigen [40, 42].
Amongst lymphocytes and macrophages, B cells were
the cells least present in granulomatous lesions in the
airways of patients with GPA. It is known in GPA that
granulomas harbor B cells in germinal center-like
lymphoid structures, and these cells are considered to
be pathogenic ANCA-secreting cells [43]. Activated B
cells are found alongside PR3-expressing cells and cells
expressing B cell activating factor (BAFF) and a
proliferation-inducing ligand (APRIL) in nasal mucosa
from patients with GPA [44]. Nonetheless, in this study
we did not find any associations between B cells and
disease parameters.
Limitations of this study include mainly its cross-
sectional nature. Longitudinal evaluation of macrophage
phenotypes in airway infiltrates from patients with GPA
(i.e. repeated biopsies of nasal mucosa) prior to com-
mencing therapy and after remission is obtained would
yield better understanding about the influence of disease
activity and therapy. Another limitation is the hetero-
geneity of biopsy sites evaluated in this study. Even
though most biopsies were performed from nasal mu-
cosa, other airway sites could behave in a different way
under the influence of different local factors.
Conclusion
M2 is the predominant macrophage phenotype in the
inflammatory infiltrate in the airways of patients with
GPA, especially in sites other than the nasal mucosa. In
addition, as a mirror of M2 macrophages, the Th2 re-
sponse is also predominant over the Th1 response in
the airways of patients with GPA. Some associations
were found between daily prednisolone dose and all
macrophage markers, between M2 macrophages and
immunosuppressive therapy and between nasal carriage
of Staphylococcus aureus and an increased number of T
cells in the airways of patients with GPA. However, in
multivariate analysis they were not shown to be inde-
pendent from other factors such as age, gender, disease
extension or therapy with co-trimoxazole.
Additional files
Additional file 1: Table S1. Analysis of lymphocytes and macrophages
in relation to disease parameters and nasal culture in GPA. Frequencies of
CD68, CD86, CD163, CD3 and CD20 were compared between patients
with GPA with localized and generalized disease and between patients
with GPA who underwent airways biopsy at disease onset and during a
disease relapse; no significant differences were observed. Evaluation of
lymphocyte and macrophage scores in relation to positive and negative
nose cultures for S. aureus yielded a significantly higher frequency of
T cells in airway lesions from patients with GPA with a positive nasal
culture for S. aureus compared with patients with GPA with a negative
nasal culture for S. aureus. No significant differences were observed in B
cell or macrophage frequencies in positivity of nasal culture for S. aureus
in the airways of patients with GPA. (PDF 248 kb)
Additional file 2: Table S2. Evaluation of lymphocyte and macrophage
scores in relation to therapy for GPA. Comparisons between patients with
GPA who were not on therapy and patients with GPA who were on
either prednisolone or immunosuppressive agents did not yield significant
results for CD3+, CD20+, CD68+, CD86+ or CD163+ cells in the airways.
Evaluation of lymphocyte and macrophage scores in relation to the use
of daily co-trimoxazole in patients with GPA with positive nose cultures for
Staphylococcus aureus. No significant differences in CD3+, CD20+, CD68+,
CD86+ or CD163+ cells in the airways were found between patients with GPA
who were or were not on daily co-trimoxazole. Evaluation of lymphocyte and
macrophage scores in relation to the use of daily co-trimoxazole in patients
with GPA with negative nose cultures for S. aureus; no significant differences
were found in CD3+, CD20+, CD68+, CD86+ or CD163+ cells in the airways
between patients with GPA who were or were not on daily co-trimoxazole.
Evaluation of lymphocyte and macrophage scores in relation to the use of
prednisolone in patients with GPA; no significant differences in CD3+, CD20+,
CD68+, CD86+ or CD163+ cells in the airways were found between patients
with GPA who were or were not on prednisolone. (PDF 153 kb)
Additional file 3: Table S3. Correlation between prednisolone daily dose
and lymphocytes and macrophages in airway biopsies from patients with
GPA. Significant correlation was found between daily dose of prednisolone
in patients with GPA and all macrophage markers. (PDF 235 kb)
Additional file 4: Table S4. Univariate linear regression to analyze
associations between macrophage markers and therapy in patients with
GPA. Significant associations were found between all macrophage markers
and daily dose of prednisolone and the use of immunosuppressive agents.
(PDF 316 kb)
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Additional file 5: Table S4. Multivariate linear regression models to
analyze associations between CD3, CD20, CD68, CD86 and CD163 scores
in airway biopsies and disease parameters/therapy in patients with GPA.
No significant associations were observed between macrophages, B cell
or T cell markers with age, gender, positive nasal culture for S. aureus,
disease extension, use of co-trimoxazole, daily dose of prednisolone or
use of immunosuppressive agents. (PDF 240 kb)
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